Sei Investments CO Mersana Therapeutics, Inc. Transaction History

Sei Investments CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.0 - $7.02 $115,908 - $203,418	28,977 New	28,977 $119,000
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $14,107 - $24,376	3,047 Added 17.66%	20,303 $137,000
Q2 2022 Aug 15, 2022	BUY	$2.84 - $5.0 $49,007 - $86,280	17,256 New	17,256 $80,000
Q3 2018 Nov 08, 2018	SELL	$10.0 - $19.02 $350 - $665	-35 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$14.2 - $22.68 $497 - $793	35 New	35 $1,000

125

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $52.5M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.